Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
4,594 results
- Anesthesia and Postoperative Pain: Complete Statistical AnalysisIndependent statistical analysis of Anesthesia and Postoperative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00232817).
- ANNOUNCE 2Independent statistical analysis of A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ANSWERIndependent statistical analysis of Adjunctive Neurovascular Support for Wide-neck Aneurysm Embolization and Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02312856).
- Anti-Diabetic Medications to Fight PD and LBD: Complete Statistical AnalysisIndependent statistical analysis of Anti-Diabetic Medications to Fight PD and LBD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06263673).
- Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04225039).
- Anti-LPS Antibody Treatment for Pediatric NAFLD: Complete Statistical AnalysisIndependent statistical analysis of Anti-LPS Antibody Treatment for Pediatric NAFLD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03042767).
- Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Anti-Tac(90 Y-HAT) to Treat Hodgkin’s Disease, Non-Hodgkin’s Lymphoma and Lymphoid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS): Complete Statistical AnalysisIndependent statistical analysis of Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03261830).
- Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin’s Lymphoma or Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Antidepressant Effects of TS-161 in Treatment-Resistant Depression: Complete Statistical AnalysisIndependent statistical analysis of Antidepressant Effects of TS-161 in Treatment-Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04821271).
- Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System: Complete Statistical AnalysisIndependent statistical analysis of Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00003508).
- Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer: Complete Statistical AnalysisIndependent statistical analysis of Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AOPDPCINVIndependent statistical analysis of Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- APACAR2Independent statistical analysis of A Comparative Study Between a Pre-hospital and an In-hospital Circulatory Support Strategy (ECMO) in Refractory Cardiac Arrest (APACAR2): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- APEGINIndependent statistical analysis of Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ): Complete Statistical AnalysisIndependent statistical analysis of Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01121172).
- APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer: Complete Statistical AnalysisIndependent statistical analysis of APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02889562).
- APMIndependent statistical analysis of APM in the Evoke SCS System to Program Patients With Chronic Pain of the Trunk and/or Limbs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- APOGEEIndependent statistical analysis of Feasibility Study on the Contribution of Guided Puncture With Echoendoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01892501).
- APOLLOIndependent statistical analysis of Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB: primary endpoint results, effect estimate with confidence interval, sample-size…
- APOSTLEIndependent statistical analysis of Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03312023).
- APP21Independent statistical analysis of Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- APP22Independent statistical analysis of Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- APPACIndependent statistical analysis of Appendicectomy Versus Antibiotics in the Treatment of Acute Uncomplicated Appendicitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01022567).
- Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias: Complete Statistical AnalysisIndependent statistical analysis of Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Application of 3D Printing Technique in Small Pulmonary Nodule Localization: Complete Statistical AnalysisIndependent statistical analysis of Application of 3D Printing Technique in Small Pulmonary Nodule Localization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02952261).
- Application of Virtual Reality in Post-Operative Recovery of a Pediatric Scoliosis Patient Population: Complete Statistical AnalysisIndependent statistical analysis of Application of Virtual Reality in Post-Operative Recovery of a Pediatric Scoliosis Patient Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- APPOSEIndependent statistical analysis of Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- APPRISE 1Independent statistical analysis of Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Appy-PATIndependent statistical analysis of Randomized Controlled Trial of a Patient Activation Tool in Pediatric Appendicitis (Antibiotics Alone vs. Appendectomy): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00659945).
- ARIndependent statistical analysis of Augmented Reality Distraction for Reducing Pain in Pediatric Dental Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06954883).
- ARBIndependent statistical analysis of Angiotensin II Blockade and Inflammation in Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01684748).
- ARCADIANIndependent statistical analysis of Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04648033).
- ARESTIndependent statistical analysis of Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection: Complete Statistical AnalysisIndependent statistical analysis of ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ARMIndependent statistical analysis of CoolSculpting the Upper Arm Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02669329).
- Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients: Complete Statistical AnalysisIndependent statistical analysis of Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ARMOURIndependent statistical analysis of Proximal Protection With The Mo.Ma Device During Carotid Stenting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00744523).
- ARRIVEIndependent statistical analysis of A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease: primary endpoint results, effect estimate with confidence interval,…
- Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ART-ADIndependent statistical analysis of Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- AS900672-Enriched in Ovulation Induction: Complete Statistical AnalysisIndependent statistical analysis of AS900672-Enriched in Ovulation Induction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553514).
- Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II: Complete Statistical AnalysisIndependent statistical analysis of Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II: primary endpoint results, effect estimate with confidence interval, sample-size…
- Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients: Complete Statistical AnalysisIndependent statistical analysis of Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ASCENTIndependent statistical analysis of Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…